- The 2025 BCTXP Certification Results
- How the Passing Score Is Actually Set
- First-Time Candidates vs. Repeat Test-Takers
- The Exam Format Behind the Numbers
- Domain Weighting and Where Candidates Lose Points
- Who Is Actually Sitting the BCTXP Exam
- What Happens If You Don't Pass
- Closing the Gap: How Prepared Candidates Study
- Frequently Asked Questions
- The 2025 BCTXP results show a 48.8% overall pass rate, with 20 passes among 41 total attempts.
- First-time candidates passed at 46.4% (13 of 28 attempts) - slightly below the overall rate.
- Passing requires a scaled score of 500 on a 200-800 scale, not a fixed percentage of correct answers.
- Therapeutics and Patient Management is worth 63% of the exam - the single biggest driver of pass/fail outcomes.
The 2025 BCTXP Certification Results
The Board of Pharmacy Specialties (BPS) publishes official certification results after each administration cycle, and the most recent published figures for the Board-Certified Transplant Pharmacist exam come from the 2025 cycle. Across all candidates who sat the BCTXP exam that year, the overall pass rate was 48.8%, reflecting 20 passes among 41 total attempts. That is a small candidate pool relative to many other BPS specialties, which is expected - transplant pharmacy is a niche practice area, and the credential is correspondingly smaller in scale.
Within that overall figure, BPS also breaks out first-time candidates separately from those retaking the exam. This distinction matters because it tells a very different story about who is passing and why. If you're trying to understand whether the exam is difficult in absolute terms or difficult because of preparation gaps, the split between first-timers and repeat test-takers is the more useful number to study - covered in detail below.
How the Passing Score Is Actually Set
A common misconception is that BPS exams are graded on a simple percentage-correct basis. They are not. The BCTXP exam uses a scaled score system ranging from 200 to 800, and the passing threshold is a scaled score of 500. Scaled scoring accounts for slight variations in item difficulty across different exam forms, so "500" does not necessarily mean "62.5% of raw points" - it means your performance, adjusted for question difficulty, met the standard BPS sets for competent practice.
This is also why raw question counts matter less than most candidates assume. Of the 150 total questions on the exam, only 125 are scored; the remaining 25 are unscored pretest items being field-tested for future exam forms. You won't know which 25 those are, so every question has to be treated as if it counts. For a deeper breakdown of exactly what a 500 scaled score requires and how BPS calculates it, see BCTXP Passing Score 2026: Exactly What You Need to Pass.
First-Time Candidates vs. Repeat Test-Takers
The 2025 data shows first-time candidates passed at 46.4%, or 13 passes among 28 attempts. That's slightly lower than the 48.8% overall rate, which makes sense: the overall figure blends first-timers with candidates who are retaking the exam after having already identified their weak areas. In other words, the gap between "first attempt" and "overall" pass rates in this dataset is modest, which suggests that retaking alone doesn't guarantee dramatically better odds - targeted preparation between attempts matters more than simply trying again.
Key Takeaway
Because first-time and overall pass rates are close, candidates should treat their first attempt as the one that matters most rather than assuming a retake will be materially easier.
The Exam Format Behind the Numbers
Understanding the pass rate requires understanding what candidates are actually up against on exam day. The BCTXP exam is administered as a computer-based test through Pearson VUE and consists of:
- 150 total questions - 125 scored, 25 unscored pretest items (indistinguishable from each other during the exam)
- 3 hours 45 minutes total, including the introduction and tutorial
- Predominantly single-answer multiple-choice items, with some multiple-response and image-supported questions permitted by BPS
- Closed-book format with forward-only navigation - you cannot skip a question or return to a submitted answer once you move on
- One optional 10-minute proctor-approved break, which counts against your total exam time
- An on-screen scientific calculator provided for calculation-based items
The forward-only navigation rule is one of the more consequential format details and is often underestimated by candidates preparing from generic pharmacy board-exam habits. There's no going back to "flag and review." Every answer is final the moment you advance. This single rule changes pacing strategy significantly, and it's a major reason candidates who haven't specifically practiced under timed, forward-only conditions tend to struggle more than their content knowledge alone would predict. A full walkthrough of exam-day mechanics is available in BCTXP Study Guide 2026: How to Pass on Your First Attempt.
Domain Weighting and Where Candidates Lose Points
The BCTXP exam content outline is organized into three domains, and their weighting is heavily skewed toward one area:
Domain 1: Solid Organ Transplantation (19%)
Covers foundational transplant-specific knowledge candidates need before they can apply therapeutic reasoning in later domains.
- Organ-specific transplant physiology and pre-transplant evaluation concepts
Domain 2: Therapeutics and Patient Management (63%)
By far the largest domain and the one that determines most pass/fail outcomes. It splits into three components: Treatment Planning (19% of the total exam), Therapeutic Implementation (23%), and Treatment Outcomes and Monitoring (21%).
- Immunosuppression regimen selection and adjustment
- Managing drug interactions and adverse effects in transplant recipients
- Monitoring for rejection, infection, and long-term graft outcomes
Domain 3: Professional Practice (18%)
Covers the practice-management and professional responsibility side of transplant pharmacy work.
- Interdisciplinary collaboration, documentation, and practice-based competencies
Given that Domain 2 alone represents nearly two-thirds of the exam, it is almost certainly the domain most responsible for the sub-50% pass rate reported in 2025. Candidates who under-allocate study time to Therapeutics and Patient Management - treating it as "one of three roughly equal domains" - are structurally mismatched against how the exam is actually weighted. For a full breakdown of each domain and its sub-components, see BCTXP Exam Domains 2026: Complete Guide to All 3 Content Areas.
| Metric | 2025 Figure |
|---|---|
| Overall pass rate | 48.8% (20 of 41 attempts) |
| First-time candidate pass rate | 46.4% (13 of 28 attempts) |
| Passing scaled score | 500 on a 200-800 scale |
| Largest domain by weight | Therapeutics and Patient Management (63%) |
Who Is Actually Sitting the BCTXP Exam
The relatively small attempt pool (41 total attempts in 2025) reflects the fact that BCTXP eligibility is genuinely restrictive. To sit the exam, a candidate needs an ACPE-accredited pharmacy degree (or qualifying international equivalent), active pharmacist licensure, and one of three qualifying pathways completed within the preceding seven years:
- Four years of postlicensure transplant practice, with at least 50% of time spent in the exam's outlined content areas
- An eligible PGY1 residency plus two years of qualifying transplant practice
- An eligible PGY2 solid-organ-transplantation pharmacy residency
Practice-based pathways also require employer attestation, which adds a documentation step many first-time applicants underestimate. This eligibility structure means nearly every candidate walking into the testing center already has substantial hands-on transplant experience - which raises an important point about the pass rate: this isn't a population of unprepared generalists. A near-50% pass rate among candidates who mostly already work in transplant pharmacy is a meaningful signal about exam difficulty. For the complete eligibility breakdown, see BCTXP Requirements 2026: Eligibility, Prerequisites & How to Qualify.
What Happens If You Don't Pass
Given the pass-rate data, it's worth understanding exactly what a failed attempt costs in time and money. BPS's current retake policy allows:
- Up to three total attempts per application cycle
- A mandatory 90-day waiting period between attempts
- After that wait, a 90-day window to schedule and complete the next attempt
- A 12-month wait before submitting a brand-new application if a third attempt fails, which also requires paying the full $600 application fee again
Retake exams cost $300, compared to the $600 initial examination fee. Given the roughly even split between first-time and overall pass rates in the 2025 data, a retake doesn't automatically raise your odds - it only helps if the 90-day gap is used to specifically address weak domains, particularly Therapeutics and Patient Management. A full cost breakdown, including annual maintenance and recertification fees, is available in BCTXP Certification Cost 2026: Complete Pricing Breakdown, and current testing windows are covered in BCTXP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
Closing the Gap: How Prepared Candidates Study
Because Domain 2 carries 63% of total exam weight across three components (Treatment Planning at 19%, Therapeutic Implementation at 23%, and Treatment Outcomes and Monitoring at 21%), the most defensible way to allocate a multi-week study plan is to weight time proportionally rather than evenly across all three domains.
Domain 1: Solid Organ Transplantation
- Build the foundational transplant physiology and evaluation knowledge that Domain 2 questions assume you already have
Domain 2: Therapeutics and Patient Management
- Spend the largest block of study time here, working through immunosuppression management, drug interaction scenarios, and outcome-monitoring case questions under timed, forward-only conditions
Domain 3: Professional Practice
- Cover practice-management content and interdisciplinary collaboration scenarios
Full-Length Practice Under Real Constraints
- Take timed, forward-only practice exams that mirror the 150-question, 3-hour-45-minute format with no ability to revisit answered items
Simulating the no-backtracking rule matters more for this exam than for most: candidates accustomed to reviewing and changing answers on other board exams often lose points simply from unfamiliar pacing pressure, not knowledge gaps. Practicing under realistic timed conditions before exam day is one of the few preparation habits directly tied to a format quirk unique to BPS specialty exams like this one. For a broader strategic walkthrough, see the BCTXP Study Guide 2026, and for a candid assessment of overall exam difficulty relative to other pharmacy credentials, see How Hard Is the BCTXP Exam? Complete Difficulty Guide 2026.
Frequently Asked Questions
The overall 2025 BCTXP pass rate was 48.8%, with 20 passes among 41 total attempts. First-time candidates passed at 46.4%, with 13 passes among 28 attempts.
No. BPS uses a scaled score from 200 to 800, and candidates need a scaled score of 500 to pass. This is not equivalent to a simple percentage of questions answered correctly.
The data doesn't show a dramatic gap between first-time (46.4%) and overall (48.8%) pass rates, suggesting that simply retaking without addressing specific domain weaknesses - especially Therapeutics and Patient Management - may not meaningfully change outcomes.
Candidates get three total attempts, with a mandatory 90-day wait between attempts. After a third failed attempt, candidates must wait 12 months before submitting a new application and paying the $600 fee again.
It accounts for 63% of the total exam - more than three times the weight of either other domain - making it the single largest determinant of whether a candidate reaches the passing scaled score of 500.